These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6148006)

  • 1. The decrease in coronary heart disease mortality. Status and perspectives on the role of cholesterol.
    Am J Cardiol; 1984 Aug; 54(5):35C-41C. PubMed ID: 6148006
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of familial and acquired hyperlipoproteinemia in children and adolescents.
    Glueck CJ
    Prev Med; 1983 Nov; 12(6):835-47. PubMed ID: 6676731
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resins in the treatment of hypercholesterolemia].
    Jacotot B
    Med Chir Dig; 1978; 7(8):697-8. PubMed ID: 745469
    [No Abstract]   [Full Text] [Related]  

  • 5. [The cholesterol question. Disinformed information].
    Bobbio M; Brusca A
    G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828
    [No Abstract]   [Full Text] [Related]  

  • 6. Response of hyperlipoproteinemia to cholestyramine resin.
    Fallon HJ; Woods JW
    JAMA; 1968 Jun; 204(13):1161-4. PubMed ID: 5694692
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid lowering effects on cardiovascular morbidity and mortality. Clinical evidence and therapeutic guidelines.
    Islami Y; Ribeiro LG
    Arq Bras Cardiol; 1988 Jul; 51(1):43-8. PubMed ID: 3073735
    [No Abstract]   [Full Text] [Related]  

  • 8. LRC-CPP trial.
    Johnstone JR
    Med J Aust; 1984 Jun; 140(12):739. PubMed ID: 6727739
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
    Maíz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM
    Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
    Day CE
    Artery; 1990; 17(5):281-8. PubMed ID: 2396902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowered cholesterol decreases heart disease.
    Kolata G
    Science; 1984 Jan; 223(4634):381-2. PubMed ID: 6362006
    [No Abstract]   [Full Text] [Related]  

  • 12. The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
    Rifkind BM
    Monogr Atheroscler; 1985; 13():74-84. PubMed ID: 3911061
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypercholesterolemia: new values, new strategies.
    Lueg MC; Anding RH
    Hosp Pract (Off Ed); 1986 Jan; 21(1A):112-3, 116-7, 120-2. PubMed ID: 3080456
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vasosan S--a cholestyramine in the treatment of hypercholesterolemia of various etiopathogenesis].
    Kolesár P
    Vnitr Lek; 1994 Feb; 40(2):89-92. PubMed ID: 8140767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of hypercholesterolemia for epidemiology, prevention and pathogenesis of coronary heart diseases].
    Gohlke H
    Dtsch Med Wochenschr; 1989 Dec; 114(50):1974-8. PubMed ID: 2689125
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of biochemical precursors of coronary heart disease.
    Ostrander LD
    Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
    Glueck CJ; Tsang RC; Fallat RW; Mellies M
    Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.